Skip to content
What is hyperbolic tapering? | The Holistic Psychiatry Clinic

Home›Resources›What is hyperbolic tapering?

Clinical explainer

What is hyperbolic tapering and why does it matter?

Most people reducing antidepressants are told to cut the dose in equal steps. Hyperbolic tapering is different, and the science behind it helps explain why so many standard tapers become difficult near the end.

Need help now? See urgent support options. We are not a crisis service.

A pale unpaved road curving towards a still lake in open moorland under a cloudy sky.

Why standard tapers stall

The problem with equal-step tapering

The usual approach is to cut the dose by a fixed amount at regular intervals, for example from 20mg to 10mg to 0mg over several weeks. It looks tidy. It does not match how antidepressants work in the brain.

The relationship between dose and effect is not a straight line. It follows a curve, which pharmacologists describe as hyperbolic. A drop from 20mg to 10mg does not have the same effect on the brain as a drop from 4mg to 2mg, even though both are a 50% cut. At lower doses, each milligram has a larger effect on the nervous system. Equal-step tapering often feels manageable at first, then much harder at the end.

A central point

Equal-step tapering often feels manageable at first, then much harder at the end.

That pattern is usually about the method, not about the person.

A different pattern

What hyperbolic tapering means

Instead of reducing by a fixed amount each time, reductions are made as a proportion of the current dose, and the absolute size of each step gets smaller as the dose gets lower.

Hyperbolic tapering compared with equal-sized steps An illustrative chart of dose against time. A dashed line shows equal-sized reductions. A solid line shows hyperbolic tapering, with steps that become smaller as the dose gets lower. DOSE TIME Higher Lower Equal-sized steps Hyperbolic tapering (smaller steps at lower doses)
Illustrative only, not a personal taper plan. The relationship between dose and effect is not a straight line, so safe reductions usually get smaller as the dose gets lower.

In practice, a taper might begin with slightly larger milligram steps while the dose is still high, then use much smaller steps, often with a liquid, once the dose is low. The percentages stay more even. The milligrams do not. This is the essence of the method: it follows the brain's sensitivity to change, rather than an arbitrary timetable.

Any example of milligram steps is illustrative only. A personal plan has to be built around the specific medicine, the starting dose, and how the person is responding.

Why the curve matters

The science behind it

The pharmacological case for hyperbolic tapering comes from research on how antidepressants occupy serotonin transporters in the brain. Work published in The Lancet Psychiatry in 2019, by Horowitz and Taylor, set out why linear tapers become harder at low doses.

  • At higher doses, transporters are already close to fully occupied, so a large milligram cut can still produce a relatively small change in occupancy
  • At lower doses, the same milligram cut produces a much larger change in occupancy
  • The relationship between dose and occupancy follows a curved, hyperbolic function, which is where the name comes from
  • This is why standard linear tapers often become difficult as the dose gets lower

This work, together with later clinical guidance, has informed NICE recommendations on depression (NG222) and on medicines associated with dependence or withdrawal (NG215), which recommend gradual, proportional reductions rather than abrupt or merely equal-step cuts. The Maudsley Deprescribing Guidelines (2024) set the approach out in practical detail.

Formulations

Why liquid formulations are often necessary

Standard tablets come in a limited set of strengths. Once the taper goes below the smallest tablet, it is hard to make accurate reductions without a different formulation.

Liquid preparations allow very small, precise doses. That precision matters most at the lower end, where each milligram has a larger effect. In the UK, liquid forms of most common antidepressants can be prescribed. We routinely issue private prescriptions for liquids as part of deprescribing support, when they are needed.

Who it is for

Who benefits from hyperbolic tapering

The method is relevant for anyone reducing a long-term antidepressant. It is particularly important for people who have been on medication for more than a year, people who had a difficult time with a standard taper, people on short half-life medicines such as venlafaxine or paroxetine, and people who notice withdrawal quickly after each reduction.

For GPs and prescribers

Hyperbolic tapering is supported by NICE NG222 and NG215, and by the Maudsley Deprescribing Guidelines (2024). Liquid formulations should be planned early, not left until the taper has already become difficult. We are happy to liaise with GPs, and we can issue private prescriptions for liquid preparations during the taper. Referral by letter is helpful but not essential. Patients can self-refer.

Our approach

How we apply hyperbolic tapering

We begin with a thorough 90-minute initial consultation. Every plan we build uses hyperbolic principles: proportional reductions, a pace guided by the person's response, and the right formulation at each stage. You will always see the same psychiatrist.

If you have tried to reduce an antidepressant before and found it very difficult, a structured hyperbolic approach is often what was missing. This page is general information and does not replace individual assessment.

The last few milligrams often take longer to reduce than the preceding months.

A conversation, not a commitment

If you would like to explore whether a medication review is right for you, send us a short enquiry. You are welcome to ask practical questions first. This is not a medical consultation.

Make an enquiry →

Or email hello@holisticpsychiatryclinic.com

We are not a crisis service

The Holistic Psychiatry Clinic is a planned outpatient service and cannot provide immediate support. If you are in acute distress or having thoughts of suicide or self-harm, or you need help now, please do not wait for a reply from us.

  • 999 or A&EIf you or someone else is in immediate danger, or you feel you cannot keep yourself safe, call 999 or go to your nearest A&E
  • NHS 111Call 111 and choose the mental health option
  • 116 123Samaritans, free, 24 hours a day
  • Your GPAsk for an urgent same-day appointment

References

  1. Horowitz MA, Taylor D (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6, 538 to 546. doi.org/10.1016/S2215-0366(19)30032-X
  2. The Maudsley Deprescribing Guidelines (2024). doi.org/10.1002/9781394291052
  3. National Institute for Health and Care Excellence. Depression in adults: treatment and management (NG222), including the section on stopping antidepressants. nice.org.uk/guidance/ng222
  4. National Institute for Health and Care Excellence. Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adults (NG215). nice.org.uk/guidance/ng215
  5. Royal College of Psychiatrists. Stopping Antidepressants (updated guidance). rcpsych.ac.uk

About this page: clinical explainer. Reviewed by Dr Suraj Gogoi, Psychiatrist. Last reviewed March 2026.